Skip to content
Glaucoma

Optic Nerve Head Drusen

Optic disc drusen (ONHD) are granular structures formed by deposition of hyaline material and calcification in the lamina cribrosa of the anterior optic nerve. They are congenital but often inconspicuous in childhood, and are frequently discovered incidentally during fundus examinations for health checkups or other diseases.

Ophthalmoscopically, they are classified into superficial and buried types.

  • Superficial type: Observed as yellowish-white nodules on the disc surface. They are translucent and best visualized by retroillumination.
  • Buried type: Presents with disc edema-like appearance and obscuration of the physiologic cup. Differentiation from pseudopapilledema is important.

The prevalence is 0.34% (clinical studies) to 2% (autopsy studies). In Japan, the incidence is 0.04%, slightly lower than in Western countries. Three-quarters of cases are bilateral, and autosomal dominant inheritance with incomplete penetrance is suggested.

In the differential diagnosis of glaucoma, optic disc drusen should be considered as one of the non-glaucomatous optic disc abnormalities1)2).

Q Are optic disc drusen the same as drusen in age-related macular degeneration?
A

They are different diseases. Drusen in age-related macular degeneration are deposits that accumulate beneath the retinal pigment epithelium and occur in the macula. Optic disc drusen are calcified deposits associated with axonal degeneration within the optic nerve head, and they differ in location, pathogenesis, and clinical significance.

Usually asymptomatic. Because visual field defects progress slowly, they are often unnoticed. Rarely, patients may complain of the following.

  • Transient visual obscuration (TVO): Reported incidence of 8.6%, thought to be secondary to transient papillary ischemia
  • Sudden vision loss or visual field defect: Thought to be caused by ischemia within the optic nerve head
  • Optic disc elevation: Lacks cupping, with blurred or irregular margins. More common on the nasal half of the disc
  • Visual field defects: Occur in 70–90% of cases. More frequent in buried than superficial drusen. Show various patterns including enlargement of the Mariotte blind spot, peripheral constriction, and arcuate scotomas
  • Retinal nerve fiber layer (NFL) thinning: Detected in eyes where drusen are visible. Often precedes visual field loss
  • Complications: Association with retinitis pigmentosa and angioid streaks. Frequent association with small optic discs. Rarely, flame-shaped hemorrhages, NA-AION, and peripapillary subretinal neovascularization occur

Superficial Drusen

Appearance: Yellow-white to pink nodules visible on the disc surface

Visual field defects: Visual field loss in 71% of eyes with visible drusen

NFL changes: Focal thinning corresponding to the quadrant with dense drusen. May also be diffuse

Diagnosis: Relatively easy to identify on fundus examination

Buried Drusen

Appearance: Edematous-appearing disc with blurred margins. Presents as pseudopapilledema

Visual field defects: Visual field loss in 25–30% of eyes presenting only with pseudopapilledema

NFL changes: Red-free photography may not show NFL changes clearly

Diagnosis: Detection of calcification by ultrasound B-mode, CT, or OCT is necessary

The exact etiology is unknown, but it is thought to be a byproduct of axonal degeneration.

  • A small scleral canal impedes normal axoplasmic flow, leading to stasis
  • Abnormal axonal metabolism causes calcium crystal deposition within mitochondria
  • Microbodies extruded into the extracellular space undergo continuous calcification and fusion

Drusen increase with age, and both NFL thinning and visual field defects progress slowly over time. Worsening of visual field constriction at a rate of about 1.6% per year has been reported.

  • Genetics: Autosomal dominant inheritance (incomplete penetrance). Taking a family history is important
  • Small optic disc (crowded disc): In small optic discs, axons are densely packed, increasing the risk of drusen formation3)

Optic disc drusen induce crowding of the optic disc and have been reported to be associated with the onset of NA-AION in patients under 50 years of age, albeit rarely3).

Elevation, cupping, and blurred margins of the optic disc are confirmed. The absence of hyperemia and microvascular abnormalities on the disc surface distinguishes it from papilledema. A comprehensive evaluation including fundus examination under mydriasis is necessary 2).

  • B-mode ultrasonography: Detects hyperechoic lesions with acoustic shadowing posterior to calcified drusen. Papilledema shows enlargement of the intraorbital optic nerve, but drusen do not.
  • CT: Visualizes calcification at the level of the optic disc using bone window settings. Also useful for differentiating from papilledema.
  • OCT: Can detect both buried and superficial drusen and is currently considered the gold standard 4). Allows quantitative assessment of peripapillary RNFL thickness. Cross-sectional images are also useful for identifying PHOMS (peripapillary hyperreflective ovoid mass structures).
  • Autofluorescence: Shows well-defined hyperfluorescence within the disc under blue light of a confocal scanning laser ophthalmoscope 4).
  • Fluorescein angiography (FA): Late focal hyperfluorescence and staining of peripapillary vessel walls. In papilledema, diffuse early leakage is seen, which helps in differentiation.
FindingOptic Disc DrusenPapilledema
ColorYellow-whiteRed
Physiological cuppingAbsentPreserved (early)
HemorrhageRarePresent
  • Papilledema: Due to increased intracranial pressure. Accompanied by hyperemia, hemorrhage, and loss of venous pulsation
  • Optic neuritis: Accompanied by acute vision loss and eye pain
  • Glaucomatous optic disc cupping: Enlarged cupping and rim thinning. No cupping in drusen1)
Q How to differentiate optic disc drusen from papilledema?
A

Optic disc drusen show no hyperemia, no capillary dilation or hemorrhage on the disc surface, and the vessels on the disc can be clearly traced. For definitive diagnosis, detection of calcification by B-mode ultrasound or OCT is useful4). Fluorescein angiography shows no dye leakage from the disc, which helps differentiate from papilledema. The absence of change in disc findings during follow-up is also important for confirming pseudopapilledema.

There is no treatment for drusen themselves. Management and treatment of complications are the mainstay.

  • Observation: Long-term monitoring of changes in optic disc drusen morphology and visual field testing. Regular follow-up is essential as it is a chronic progressive disease.
  • Intraocular pressure management: Lowering intraocular pressure may have a neuroprotective effect, but its efficacy in ONHD has not been established.
  • Complication treatment: If choroidal neovascularization occurs, consider photocoagulation. If NA-AION is complicated, manage accordingly.
Q Can optic disc drusen be cured?
A

Currently, there is no treatment to eliminate optic disc drusen. Drusen tend to increase with age. However, visual impairment is usually mild, and sudden vision loss is rare. The best approach is regular examinations for early detection and management of complications.

6. Pathophysiology and detailed pathogenesis

Section titled “6. Pathophysiology and detailed pathogenesis”

Axonal degeneration and calcium deposition

Section titled “Axonal degeneration and calcium deposition”

Ultrastructural studies of optic disc drusen show the following process:

  1. A small scleral canal physically obstructs axonal flow, causing stasis within the axon.
  2. Needle-like calcium crystals deposit within axonal mitochondria.
  3. The plasma membrane is disrupted, and axonal components leak into the interstitial space.
  4. Severe calcium crystal deposits accumulate in extracellular mitochondria.
  5. Microbodies continuously calcify and fuse, forming colloid bodies 5 to 1000 μm in diameter.

Drusen vary from 2–3 small nodules to aggregates of up to 40–50.

The causes of visual field defects are thought to include direct compression of optic nerve fibers by drusen, ischemia of the optic disc, and impaired axonal transport 3). The size and location of optic disc drusen do not always correspond to the visual field defects.

Drusen are aggregates of calcified material that accumulate due to changes in axonal transport and worsen crowding of the optic disc. This is rarely associated with the development of NA-AION, especially in patients under 50 years of age 3). In a multicenter retrospective study, optic disc drusen were identified by OCT in more than 50% of NA-AION patients under 50 years of age 3).

7. Recent Research and Future Perspectives

Section titled “7. Recent Research and Future Perspectives”

OCT is currently considered the gold standard imaging method for noninvasively detecting both buried and superficial drusen 4). It can identify buried drusen and detect PHOMS on cross-sectional images, and is also useful for detecting non-calcified buried drusen that were missed by conventional B-mode ultrasound.

Long-term Prognosis of Visual Field Progression

Section titled “Long-term Prognosis of Visual Field Progression”

Optic disc drusen is a chronic progressive optic nerve disease, with a reported worsening of visual field constriction of about 1.6% per year. Thinning of the NFL correlates with the degree of clinically visible drusen and often precedes visual field defects.

Optic disc drusen are rarely associated with the development of NA-AION. Particularly in patients under 50 years of age, drusen may induce excessive crowding of the optic disc and increase the risk of ischemia 3).

  • Verification of whether lowering intraocular pressure suppresses the progression of visual field defects in ONHD
  • Evaluation of the efficacy of vasoactive therapies such as pentoxifylline
  • Development of an automated detection system for buried drusen using AI and deep learning
  1. American Academy of Ophthalmology. Primary Open-Angle Glaucoma Preferred Practice Pattern. Ophthalmology. 2021;128:P51-P124.

  2. American Academy of Ophthalmology. Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern. Ophthalmology. 2020;127:P97-P133.

  3. Salvetat ML, Pellegrini F, Spadea L, et al. Non-Arteritic Anterior Ischemic Optic Neuropathy (NA-AION)—A Comprehensive Review. Vision. 2023;7:72.

  4. Mollan SP, Mytton J, Tsermoulas G, et al. Idiopathic Intracranial Hypertension: Evaluation of Admissions and Emergency Readmissions through the Hospital Episode Statistic Dataset between 2002-2020. Life (Basel). 2021;11(5):417. doi:10.3390/life11050417.

Copy the article text and paste it into your preferred AI assistant.